Microglial content-dependent inhibitory effects of calcitonin gene-related peptide (CGRP) on murine retroviral infection of glial cells.
Jennifer T Malon, Eliza Grlickova-Duzevik, James Vaughn, Holly Beaulac, Tyler R Vunk, Ling Cao
Index: J. Neuroimmunol. 279 , 64-70, (2015)
Full Text: HTML
Abstract
C57BL/6 (B6) mice develop peripheral neuropathy post-LP-BM5 infection, a murine model of HIV-1 infection, along with the up-regulation of select spinal cord cytokines. We investigated if calcitonin gene-related peptide (CGRP) contributed to the development of peripheral neuropathy by stimulating glial responses. An increased expression of lumbar spinal cord CGRP was observed in vivo, post-LP-BM5 infection. Consequently, in vitro CGRP co-treatments led to a microglial content-dependent attenuation of viral loads in spinal cord mixed glia infected with selected doses of LP-BM5. This inhibition was neither caused by the loss of glia nor induced via the direct inhibition of LP-BM5 by CGRP. Copyright © 2015 Elsevier B.V. All rights reserved.
Related Compounds
Related Articles:
2014-10-01
[J. Neurophysiol. 112(7) , 1628-43, (2014)]
2014-10-01
[J. Biomol. Screen. 19(9) , 1266-74, (2014)]
2015-05-12
[Biochemistry 54 , 2841-50, (2015)]
2014-12-01
[J. Biochem. Mol. Toxicol. 28(12) , 568-77, (2014)]
2015-01-01
[PLoS ONE 10 , e0134768, (2015)]